Figure 1. Current and emerging routes of open innovation in the pharmaceutical industry. Besides the traditional open innovation approaches (in/out-licensing, co-development, co-commercialization, acquisition, spin-out/divestiture), the industry is selectively opening up boundaries and is exploring open innovation approaches to bring in new ideas and product opportunities to fill or enrich its pipe-line. Source: Joost Bakker (Scicomvisuals).